Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation

Recruiting Observational Study
Liver Dysfunction
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
300 (estimated)
Sponsor
University of Alberta · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

INTERLIVER is a prospective observational study of the relationship of the molecular phenotype of 300 liver transplant biopsies to the histologic phenotype and the clinical features and outcomes. A segment of a biopsy performed as standard-of-care for indications, or by center protocol, will be used for gene expression study.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * biopsy for clinical indications Exclusion Criteria: * no consent, pregnant women
Contacts

Konrad S Famulski, PhD

1 780 492 1725

konrad@ualberta.ca

CONTACT

Robert Polakowski, PhD

1 780 492 5091

polakows@ualberta.ca

CONTACT